MST1/MST2 Protein Kinases: Regulation and Physiologic Roles

Overview

Journal Biochemistry

Specialty Biochemistry

Date 2016 Sep 13

PMID 27618557

Citations 47

Authors

Jacob A Galan

Joseph Avruch

Affiliations

Soon will be listed here.

Abstract

The MST1 and MST2 protein kinases comprise the GCK-II subfamily of protein kinases. In addition to their amino-terminal kinase catalytic domain, related to that of the Saccharomyces cerevisiae protein kinase Ste20, their most characteristic feature is the presence near the carboxy terminus of a unique helical structure called a SARAH domain; this segment allows MST1/MST2 to homodimerize and to heterodimerize with the other polypeptides that contain SARAH domains, the noncatalytic polypeptides RASSF1-6 and Sav1/WW45. Early studies emphasized the potent ability of MST1/MST2 to induce apoptosis upon being overexpressed, as well as the conversion of the endogenous MST1/MST2 polypeptides to constitutively active, caspase-cleaved catalytic fragments during apoptosis initiated by any stimulus. Later, the cleaved, constitutively active form of MST1 was identified in nonapoptotic, quiescent adult hepatocytes as well as in cells undergoing terminal differentiation, where its presence is necessary to maintain those cellular states. The physiologic regulation of full length MST1/MST2 is controlled by the availability of its noncatalytic SARAH domain partners. Interaction with Sav1/WW45 recruits MST1/MST2 into a tumor suppressor pathway, wherein it phosphorylates and activates the Sav1-bound protein kinases Lats1/Lats2, potent inhibitors of the Yap1 and TAZ oncogenic transcriptional regulators. A constitutive interaction with the Rap1-GTP binding protein RASSF5B (Nore1B/RAPL) in T cells recruits MST1 (especially) and MST2 as an effector of Rap1's control of T cell adhesion and migration, a program crucial to immune surveillance and response; loss of function mutation in human MST1 results in profound immunodeficiency. MST1 and MST2 are also regulated by other protein kinases, positively by TAO1 and negatively by Par1, SIK2/3, Akt, and cRaf1. The growing list of candidate MST1/MST2 substrates suggests that the full range of MST1/MST2's physiologic programs and contributions to pathophysiology remains to be elucidated.

Citing Articles

The Hippo Signaling Pathway, Reactive Oxygen Species Production, and Oxidative Stress: A Two-Way Traffic Regulation.

Amanda B, Pragasta R, Cakrasana H, Mustika A, Faizah Z, Oceandy D Cells. 2024; 13(22).

PMID: 39594616 PMC: 11592687. DOI: 10.3390/cells13221868.

The long noncoding RNA ELFN1-AS1 promotes gastric cancer growth and metastasis by interacting with TAOK1 to inhibit the Hippo signaling pathway.

Wang Y, Shen K, Cheng Q, Zhou X, Liu K, Xiao J Cell Death Discov. 2024; 10(1):465.

PMID: 39528458 PMC: 11555383. DOI: 10.1038/s41420-024-02235-5.

Mst1-mediated phosphorylation of FoxO1 and C/EBP-β stimulates cell-protective mechanisms in cardiomyocytes.

Maejima Y, Nah J, Aryan Z, Zhai P, Sung E, Liu T Nat Commun. 2024; 15(1):6279.

PMID: 39060225 PMC: 11282193. DOI: 10.1038/s41467-024-50393-y.

STK3 kinase activation inhibits tumor proliferation through FOXO1-TP53INP1/P21 pathway in esophageal squamous cell carcinoma.

Zhao Z, Chu Y, Feng A, Zhang S, Wu H, Li Z Cell Oncol (Dordr). 2024; 47(4):1295-1314.

PMID: 38436783 PMC: 11322239. DOI: 10.1007/s13402-024-00928-8.

Association of MST1 in the First Trimester of Pregnancy with Gestational Diabetes Mellitus and Adverse Pregnancy Outcomes.

Gao B, Zhang Q, Dong S, Gao F, Liu X, Wei J Diabetes Metab Syndr Obes. 2024; 17:19-29.

PMID: 38192496 PMC: 10773263. DOI: 10.2147/DMSO.S436178.

References

Huser M, Luckett J, Chiloeches A, Mercer K, Iwobi M, Giblett S . MEK kinase activity is not necessary for Raf-1 function. EMBO J. 2001; 20(8):1940-51. PMC: 125235. DOI: 10.1093/emboj/20.8.1940. View

Donninger H, Schmidt M, Mezzanotte J, Barnoud T, Clark G . Ras signaling through RASSF proteins. Semin Cell Dev Biol. 2016; 58:86-95. PMC: 5034565. DOI: 10.1016/j.semcdb.2016.06.007. View

Rawat S, Creasy C, Peterson J, Chernoff J . The tumor suppressor Mst1 promotes changes in the cellular redox state by phosphorylation and inactivation of peroxiredoxin-1 protein. J Biol Chem. 2013; 288(12):8762-8771. PMC: 3605693. DOI: 10.1074/jbc.M112.414524. View

Yi C, Yuan J . The Jekyll and Hyde functions of caspases. Dev Cell. 2009; 16(1):21-34. PMC: 2850564. DOI: 10.1016/j.devcel.2008.12.012. View

Mardin B, Lange C, Baxter J, Hardy T, Scholz S, Fry A . Components of the Hippo pathway cooperate with Nek2 kinase to regulate centrosome disjunction. Nat Cell Biol. 2010; 12(12):1166-76. PMC: 3939356. DOI: 10.1038/ncb2120. View

Lee K, Ohyama T, Yajima N, Tsubuki S, Yonehara S . MST, a physiological caspase substrate, highly sensitizes apoptosis both upstream and downstream of caspase activation. J Biol Chem. 2001; 276(22):19276-85. DOI: 10.1074/jbc.M005109200. View

Nguyen L, Matallanas D, Romano D, Kholodenko B, Kolch W . Competing to coordinate cell fate decisions: the MST2-Raf-1 signaling device. Cell Cycle. 2015; 14(2):189-99. PMC: 4353221. DOI: 10.4161/15384101.2014.973743. View

Callus B, Verhagen A, Vaux D . Association of mammalian sterile twenty kinases, Mst1 and Mst2, with hSalvador via C-terminal coiled-coil domains, leads to its stabilization and phosphorylation. FEBS J. 2006; 273(18):4264-76. DOI: 10.1111/j.1742-4658.2006.05427.x. View

Nishiyama A, Masutani H, Nakamura H, Nishinaka Y, Yodoi J . Redox regulation by thioredoxin and thioredoxin-binding proteins. IUBMB Life. 2002; 52(1-2):29-33. DOI: 10.1080/15216540252774739. View

10.

Udan R, Kango-Singh M, Nolo R, Tao C, Halder G . Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway. Nat Cell Biol. 2003; 5(10):914-20. DOI: 10.1038/ncb1050. View

11.

Yuan Z, Kim D, Shu S, Wu J, Guo J, Xiao L . Phosphoinositide 3-kinase/Akt inhibits MST1-mediated pro-apoptotic signaling through phosphorylation of threonine 120. J Biol Chem. 2009; 285(6):3815-3824. PMC: 2823523. DOI: 10.1074/jbc.M109.059675. View

12.

Abdollahpour H, Appaswamy G, Kotlarz D, Diestelhorst J, Beier R, Schaffer A . The phenotype of human STK4 deficiency. Blood. 2012; 119(15):3450-7. PMC: 3325036. DOI: 10.1182/blood-2011-09-378158. View

13.

Pantalacci S, Tapon N, Leopold P . The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila. Nat Cell Biol. 2003; 5(10):921-7. DOI: 10.1038/ncb1051. View

14.

Chan E, Nousiainen M, Chalamalasetty R, Schafer A, Nigg E, Sillje H . The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene. 2005; 24(12):2076-86. DOI: 10.1038/sj.onc.1208445. View

15.

Ye X, Deng Y, Lai Z . Akt is negatively regulated by Hippo signaling for growth inhibition in Drosophila. Dev Biol. 2012; 369(1):115-23. DOI: 10.1016/j.ydbio.2012.06.014. View

16.

Yuan F, Xie Q, Wu J, Bai Y, Mao B, Dong Y . MST1 promotes apoptosis through regulating Sirt1-dependent p53 deacetylation. J Biol Chem. 2011; 286(9):6940-5. PMC: 3044949. DOI: 10.1074/jbc.M110.182543. View

17.

Wilkinson D, Hansen M . LC3 is a novel substrate for the mammalian Hippo kinases, STK3/STK4. Autophagy. 2015; 11(5):856-7. PMC: 4509446. DOI: 10.1080/15548627.2015.1017197. View

18.

Lavoie H, Therrien M . Regulation of RAF protein kinases in ERK signalling. Nat Rev Mol Cell Biol. 2015; 16(5):281-98. DOI: 10.1038/nrm3979. View

19.

Brent M, Anand R, Marmorstein R . Structural basis for DNA recognition by FoxO1 and its regulation by posttranslational modification. Structure. 2008; 16(9):1407-16. PMC: 2597217. DOI: 10.1016/j.str.2008.06.013. View

20.

Zhou D, Zhang Y, Wu H, Barry E, Yin Y, Lawrence E . Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc Natl Acad Sci U S A. 2011; 108(49):E1312-20. PMC: 3241824. DOI: 10.1073/pnas.1110428108. View